Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China.

AIM Subclinical hepatic encephalopathy (SHE) is a common complication of liver diseases. The aim of this study was to find out the normal value of psychometric test and to investigate the prevalence of SHE in Chinese patients with stabilized hepatic cirrhosis. METHODS Four hundred and nine consecutive cirrhotic patients without overt clinical encephalopathy were screened for SHE by using number connection test part A (NCT-A) and symbol digit test (SDT). SHE was defined as presence of at least one abnormal psychometric test. The age-corrected normal values were defined as the mean+/-2 times standard deviation (2SD), and developed in 356 healthy persons as normal controls. Four hundred and sixteen patients with chronic viral hepatitis were tested as negative controls to assess the diagnostic validity of this test battery. RESULTS There was no significant difference in NCT scores and SDT quotients between healthy controls and chronic hepatitis group (P>0.05). In all age subgroups, the NCT and SDT measurements of cirrhotic patients differed significantly from those of the controls (P<0.05). When mean+/-2SD of SDT and NCT measurements from healthy control group was set as the normal range, 119 cirrhotic patients (29.1%) were found to have abnormal NCT-A and SDT tests, 53 (13.0%) were abnormal only in SDT and 36 (8.8%) only in NCT-A. Taken together, SHE was diagnosed in 208 (50.9%) cirrhotic patients by this test battery. The prevalence of SHE increased from 39.9% and 55.2% in Child-Pugh's grade A and B groups to 71.8% in Child-Pugh's grade C group (P<0.05). After the adjustment of age and residential areas required from the tests, no correlation was found in the rate of SHE and causes of cirrhosis, education level and smoking habit. CONCLUSION Psychometric tests are simple and reliable indicators for screening SHE among Chinese cirrhotic patients. By using a NCT and SDT battery, SHE could be found in 50.9% of cirrhotic patients without overt clinical encephalopathy. The prevalence of SHE is significantly correlated with the severity of liver functions.

[1]  C. McClain,et al.  Psychomotor performance defects in cirrhotic patients without overt encephalopathy. , 1980, Archives of internal medicine.

[2]  A. Davies,et al.  The influence of age on trail making test performance. , 1968, Journal of clinical psychology.

[3]  P. Angeli,et al.  Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests , 1999, Hepatology.

[4]  T E Starzl,et al.  Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. , 1984, Gastroenterology.

[5]  R. Dhiman,et al.  Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis , 2001, Journal of gastroenterology and hepatology.

[6]  S. Sarin,et al.  Comparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: search for a rational approach. , 1989, The American journal of gastroenterology.

[7]  C. Randolph,et al.  Neuropsychological characterization and detection of subclinical hepatic encephalopathy. , 1996, Archives of neurology.

[8]  M. Zeneroli,et al.  Interindividual variability of the number connection test. , 1992, Journal of hepatology.

[9]  D. Metz,et al.  Helicobacter pylori Infection Is Not Associated with Subclinical Hepatic Encephalopathy in Stable Cirrhotic Patients , 2001, Digestive Diseases and Sciences.

[10]  D. Freides,et al.  Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. , 1978, Gastroenterology.

[11]  P. Penev,et al.  High prevalence of sleep disturbance in cirrhosis , 1998, Hepatology.

[12]  L. Jia,et al.  [Subclinical hepatic encephalopathy]. , 1996, Zhonghua nei ke za zhi.

[13]  Y. Joshi,et al.  Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy. , 2002, Liver.

[14]  K. Tanikawa,et al.  Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy , 1997, Hepatology.

[15]  A. Lockwood,et al.  Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998 , 2002, Hepatology.

[16]  H Schomerus,et al.  Latent portasystemic encephalopathy , 1981, Digestive Diseases and Sciences.

[17]  R. Dhiman,et al.  Figure connection test: A universal test for assessment of mental state , 1995, Journal of gastroenterology and hepatology.

[18]  Manuel Romero-Gómez,et al.  Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy , 2001, American Journal of Gastroenterology.

[19]  Y. Nie,et al.  [An epidemiological survey of subclinical hepatic encephalopathy]. , 2003, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[20]  H. Yoo,et al.  Relationship of the Model for End-Stage Liver Disease (MELD) Scale to Hepatic Encephalopathy, as Defined by Electroencephalography and Neuropsychometric Testing, and Ascites , 2003, American Journal of Gastroenterology.

[21]  N. Gitlin,et al.  The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. , 1986, Journal of hepatology.

[22]  Y. Chawla,et al.  Efficacy of Lactulose in Cirrhotic Patients with Subclinical Hepatic Encephalopathy , 2000, Digestive Diseases and Sciences.